The aim of the study was an evaluation of changes in protein level and activity of SOD isoenzymes, and the participation of AP-1 and NF-κB in subsequent stages of colorectal cancer development. Studies were conducted on 65 colorectal cancers. Controls were unchanged colon regions. Activity of SOD isoenzymes, lipid peroxidation level (TBARS), and protein level of SOD1, SOD2, AP-1 and NF-κB were determined. We found that the protein level and activity of SOD isoenzymes and protein level of AP-1 and NF-κB change in subsequent stages of clinical advancement of colorectal cancer, according to UICC (I-IV), and in grades of tumor cells differentiation (G 1 -G 3 ). These results indicate adaptation of colorectal cancer cells to oxidative stress, and show that the observed changes of SOD activity and protein level depend on gradual progression of colorectal cancer, and suggest an impairment of processes regulated by AP-1 and NF-κB which are critical for tumor progression (proliferation, differentiation and apoptosis).
INTRODUCTION
Colorectal cancer (CRC) is the third most common cancer worldwide. The incidence of CRC is higher in countries in the developed world, where it is the second most common cancer. CRC has a leading position in malignant cancer-related morbidity and mortality.
The percentage ratio of CRC mortality in the Polish population, was 10.6 for women and 19.17 for men in 2004 (according to the Polish National Cancer Registry). The risk factors for colorectal cancer are: hereditary genetic predisposition (i.e. familial adenomatous polyposis), age, ulcerative colitis and other colon inflammatory diseases, diets high in meat and fat or low in selenium, Lynch syndrome, smoking, and others (Benson, 2007) 1 .
Colon cancers most commonly occur in the large intestine. The predominant localization of CRC is rectum (50-60%) and sigmoid colon (15-25%). Tumors of epithelial origin are definitely the most frequent, among them adenocarcinoma is ubiquitous.
The development of CRC is multistage, beginning with a small dysplasia or polyp, and eventually leading to the appearance of distant metastases to other organs (Ballinger & Anggianasah, 2007) .
Growing evidence indicates the participation of reactive oxygen species (ROS) and their reactive derivatives in the arising and development of colorectal cancer. Inflammantion and environmental factors (nutrition antigenes, bacteria, fungi, parasites), lead to the generation of large amounts of ROS in colon tissue, and in consequence to oxidative stress. Reactive oxygen species damage DNA, proteins and lip-ids, leading to initiation of tumor changes (Conner & Grisham, 1996; Olinski et al., 1998; Ohshima et al., 2003; Hussain et al., 2003; Itzkowitz & Yio, 2004; ) .
Superoxide dismutase (SOD) is a key antioxidant enzyme, scavenging the superoxide radical (O 2 -), which is a precursor molecule for all other reactive oxygen species and their derivatives. By scavenging O 2 -, SOD form the first line of defence against oxidative stress and its subsequent effects. In human cells three isoenzymes of SOD exist: cytosolic (Cu,Zn-SOD; SOD1), mitochondrial (Mn-SOD; SOD2) and extracellular (EC-SOD, SOD3). Disturbances in the functioning of the SOD isoforms lead to numerous pathological changes in the human organism, including tumor disease (Zelko et al., 2002; Johnson & Giulivi, 2005) .
Expression of SOD genes is regulated by numerous transcription factors, particularly those sensitive to oxidative stress: AP-1 (activating protein 1) and NF-κB (nuclear factor κB). Synthesis and activation of AP-1 and NF-κB are among the most important components of the cell response to oxidative stress, and participate in decisions concerning cell survival (proliferation, growth and differentiation) or death (apoptosis) (Karin, 1995; 1999; Wang et al., 2002; Shaulian & Karin, 2002; Bubici et al. 2006) .
Tumor cells are particularly exposed to high oxidative stress conditions, and the role of AP-1 and NF-κB in the regulation of SOD gene expression should have an even greater meaning in tumor than in normal cells (Greten & Karin, 2004; Kundu & Surh, 2004; Nicco et al., 2005) . The role of SOD and AP-1 and NF-κB in colorectal cancer progression is still not exactly understood.
Although many authors have studied expression and activities of SOD isoenzymes in tumors, they reported conflicting results. Some of them observed increased expression and activity of SOD isoenzymes in various types of tumors (Janssen et al., 1999; Kanbagli et al., 2000; Devi et al., 2000; Hileman et al., 2004) , while others showed a decreased or unchanged expression and activity of SOD isoenzymes (Casaril et al., 1994 , Van Driel et al., 1997 Jung et al., 1997; Preuss et al., 2000; Wang et al., 2005) . One explanation of such discrepancies is that they studied tumors in different stages of clinical advancement.
The aim of our work was to determine if the SOD isoenzymes' protein level and their activity depend on the stage of clinical advancement of CRC. We evaluated the protein level and activity of SOD isoenzymes (SOD1, SOD2) and the participation of transcription factors AP-1 and NF-κB in subsequent stages of clinical advancement (UICC) and the grade of differentiation (G) of human colorectal cancer.
MATeRIAlS AND MeThODS
Patients and tumor characteristic. Studies were conducted on a group of 65 patients, mean age 62 ± 9.7 years (range 44-82), operated on for colorectal cancer, histological type -adenocarcinoma (Table 1). The time since the diagnosis of cancer varied from a minimum of 3 weeks to a maximum of 2 months.
Patients were hospitalized in the Department of General and Gastroenterological Surgery and Nutrition, the Department of General, Transplantation and Liver Surgery, and in the Department of General and Transplantation Surgery at the Warsaw Medical University.
Cancer specimens were taken by surgery, and normal mucosa (control tissue) was taken from corresponding adjacent tissue more than 6-7 cm away from tumor border (histologically examined).
Cancers were diagnosed by routine surgical and histopathological examination.
Evaluation of colorectal cancer clinical advancement involves such cancer features as: size, penetration of colon tissue and outside, lymph node and vascular invasion, presence of distant metastases. Those features allow exact determination of the clinical advancement stage, according to a classification known as UICC (Union Internationale Contre le Cancer) based on the TNM (Tumor, Node, Metastases) division.
During the development of CRC, cancer cells undergo gradual dedifferentiation. According to WHO, for evaluation of differentiation of cancer cells and tumor maturity, the G (grading) classification is applied. The grade reflects the degree of cellular differentiation and refers to how much the tumor cells resemble or differ from the normal cells of the same tissue type (Ballinger & Anggiansah, 2007) .
Exclusion criteria. Patients were nonsmokers, and not treated by radio-or chemotherapy before surgery. 
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Sample preparation. Directly after surgery, tissue specimens were washed in cold 0.9% NaCl and frozen at -70 o C. Then the tissues were cut to smaller pieces and homogenized in 9 vol. of cooled 100 mM Tris/HCl buffer (pH 7.5) containing 100 mM KCl, 1% (v/v) Triton X-100, and 0.5 mM PMSF, in a Heidolph Diax homogenizer. After 30 min of extraction on a magnetic stirrer, homogenates were frozen at -70 o C. After 24 h they were thawed and centrifuged at 12 000×g for 30 min at 4 o C. The obtained tissue extracts (supernatants) were used for determination of Cu,Zn-SOD and Mn-SOD activity and protein level of SOD isoenzymes, AP-1 and NF-κB.
Biochemical analyses. a) Determination of lipid peroxidation level. One of the consequences of oxidative stress in cells is lipid peroxidation. This is a chain reaction whose end products (malondialdehyde, 4-hydoxynonenal, and others) are used as markers of lipid peroxidation level, and indirectly as markers of oxidative stress intensity. The lipid peroxidation level was expressed as the concentration of substances reacting with thiobarbituric acid (TBARS). The concentration of TBARS was measured according to the method described by Ohkawa et al. (1979) .
b) Determination of activity of SOD isoenzymes. The activity of SOD1 was measured by a standard RanSOD kit purchased from Randox. This method applies xanthine and xanthine oxidase to generate superoxide anion which reacts with 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium chloride (INT) to form a red formazan dye. The superoxide dismutase activity is then measured by the degree of inhibition of this reaction. It is specific for SOD1 activity only.
The activity of SOD2 was determined according to the method described by Beauchamp and Fridovich (1971) , modified by Oberley and Spitz (1984) . The superoxide anion generated by xanthine oxidase reacts with 2,2'-di-p-nitrophenyl-5,5'-diphenyl-3,3'-[3,3'-dimethoxy-4,4'-diphenylene]-ditetrazolium chloride (nitro blue tetrazolium -NBT) forming a blue dye. Manganese superoxide dismutase activity is then measured by the degree of inhibition of this reaction. Application of NaCN which is a SOD1 inhibitor renders this reaction specific for SOD2 activity.
c) Determination of protein levels of SOD isoenzymes and transcription factors. Protein levels of SOD1, SOD2, AP-1 and NF-κB were determined using a standard Western blotting technique. Immunoelectrophoretic determination of SOD isoforms and the AP-1 and NF-κB transcription factors was performed by separation of samples prepared according to the method described by Laemmli (1970) on a 14% polyacrylamide gel containing 0.1% sodium dodecyl sulfate. This was followed by semi-dry electrotransfer on to a PVDF membrane. To block nonspecific binding, the PVDF membrane was preincubated with TTBS (Tris-buffered saline, pH 7.6, containing 0.05% Tween-20 and 10% nonfat milk) for 1 h. The membrane was then incubated with anti-SOD1, anti-SOD2, anti-AP-1 or anti-NF-κB antibodies for 1.5 h at room temperature. After incubation, the membrane was washed with TTBS and then incubated with secondary antibodies conjugated with horseradish peroxidase (Ausubel et al., 2000) . The bound antibodies were detected by chemiluminescence with the ECL kit (Amersham Life Sciences).
The amount of the proteins studied was measured densitometrically using a relative level (optical density) UVI-KS 4000 I camera and programs ScionImage and ZERO-DSCAN.
Polyclonal anti-SOD1 and anti-SOD2 antibodies were purchased from Calbiochem, and diluted 1 : 2 000 and 1 : 500, respectively. Monoclonal anti-p65 and anti c-Jun antibodies were purchased from Sigma and diluted 1 : 1 000 and 1 : 500, respectively. The presence of p65, c-Jun and Cu,Zn-SOD in the biological material examined was confirmed with the use of protein standards: recombinant human p65 and cJun and purified SOD1 enzyme from human erytrocytes. The presence of SOD2 protein was confirmed on the basis of its known subunit molecular weight with the use of molecular weight marker (Rainbow Colour High Range).
To confirm equal load of proteins on the gel, after removal of antibodies by stripping in reducing buffer, the PVDF membrane was incubated again with antibodies against actin (Santa Cruz).
Statistical analysis. The data of TBARS level, and the activity and protein level of SOD isoenzymes, and the levels of transcription factors AP-1 and NF-κB, are presented as mean values and standard deviations (x ± S.D.). The level of TBARS is expressed in nmol/mg of total protein, the activity of SOD isoforms in U/mg of total protein, and the amount of studied proteins in optical density values (OD).
Statistical analysis of data was conducted using Statistica 6.0 programme. Student's t-test and Wilcoxon test were applied for comparison of variables.
Studies were approved by the Bioethics Committee the Warsaw Medical University (decision KB/164/2001), and informed consent was obtained from all patients.
ReSUlTS

level of lipid peroxidation
The highest level of lipid peroxidation was observed in stage I of CRC clinical advancement (UICC) and G 1 grade of tumor cell differentiation (G 1 -G 3 ). In stages II, III and IV the level of TBARS was lower than in stage I, and even lower than in control.
The lowest level of TBARS comparing with control and G 1 grade was observed in G 2 grade. In the G 3 differentiation grade an increased level of TBARS was found in comparison with the G 2 grade (Fig. 2a, b) .
Activity of SOD1 and SOD2
In all stages of colorectal cancer development (UICC I-IV, G 1 -G 3 ) similar levels of SOD1 activity were found. In comparison with the control, significant changes of SOD1 activity were observed in stages I and II of UICC. Comparing to the control, the activity of SOD1 in colorectal cancer G 1 grade was increased, in G 2 was at the control level, and in G 3 decreased (Fig. 3a, b) .
The highest activity of SOD2 was observed in stages II and IV of UICC, comparing with stages I, III, and control. There were no significant changes of SOD2 activity in the G 1 -G 3 grades of CRC differentiation. In stages I and III the activity of SOD1 was distinctly higher, whereas in stages II and IV the activity of SOD2 was higher (Fig. 3a, b) .
Protein levels of SOD isoenzymes and transcription factors AP-1 and NF-κB
In stages I and IV of UICC a very high level of SOD1 protein was observed, and relatively lower protein levels of SOD2, AP-1 and NF-κB. In comparison with stage I of UICC, in stage II we observed a distinct (54%) decrease of SOD1 protein level and simultaneously increased protein levels of SOD2, AP-1 and NF-κB. In stage III, the protein levels of SOD1 and SOD2 were similar, while those of AP-1 and NF-κB were substantially less abundant. A low level of NF-κB was also seen in stage IV of UICC. The highest level of SOD1 protein was observed in stages I and IV, and SOD2 in II and III. The highest level of both transcription factors (AP-1 and NF-kB) was in stage II of UICC, and the lowest in stage III.
The protein levels of SOD1 and NF-kB were lower in subsequent grades of differentiation (G 2 and G 3 ) of CRC in comparison with the G 1 stage. SOD2 protein level was the highest in G 1 grade, and the lowest in G 2 , whereas the AP-1 protein level was the lowest in G 2 grade comparing to G 1 and G 3 (Fig. 4a, b) .
DiSCuSSiOn
We observed significant differences in the activity and protein level of both SOD isoenzymes, and the protein level of transcription factors AP-1 and NF-κB among the subsequent stages of CRC development. Those differences were associated with different levels of TBARS and seem to be due to the redox state of tumor cells, which differ depending on the advancement stage of colorectal cancer.
Since the lipid peroxidation level corresponds to the level of oxidative stress, our results 
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indicate oxidative stress conditions at the initial stages of CRC clinical advancement (UICC I) and differentiation (G 1 ). In the subsequent stages of CRC development, regarding both clinical advancement (II-IV) and differentiation (G 2 -G 3 ), the oxidative stress seems to be low. Therefore, the oxidative stress at the initial stages of CRC development might be a result of accompanying inflammation. The oxidative stress might be regarded as selective pressure, and only those tumor cells that adapt to it would be able to undergo further cancer development (Huang et al., 2000; Pelicano et al., 2004) . This might explain the low level of lipid peroxidation in subsequent stages of CRC development.
The study results show that during whole cancer development tumor cells have a stable level of antioxidative defense provided by SOD1 present in the cytosol. However, an increased protein level of SOD1 might be a response to the high level of ROS which has been previously confirmed by Yoo et al. (1999a) . This might suggest that ROS present in tumor cells stimulate the expression of SOD1 protein, but simultaneously partly reduce SOD1 activity. Despite the low level of lipid peroxidation, it seems that ROS still might affect the antioxidant defense of tumor cell, which has been shown in the earlier studies (Suh et al., 1999; Nicco et al., 2005) . This suggests that SOD1, despite its low activity could be able to defend cellular structures against oxidative stress.
The activity of the mitochondrial isoenzyme -SOD2 -varies significantly in the subsequent stages of UICC, but is almost unchanged in all stages of CRC differentiation.
This result indicates that the changes of SOD2 activity during CRC development have a distinctly periodic character, that is: it decreases in stage I, followed by an increase in stage II, a decrease in stage III and again an increase in stage IV. The factor that could cause such changes in SOD2 activity might be its product -hydrogen peroxide (H 2 O 2 ), which is able to reversibly inhibit SOD activity via a feedback mechanism. In previously published papers (Mao et al., 1993; Koningsberger et al., 1994; Bergendi et al., 1999; Antunes & Cadenas, 2001 ) this feedback inhibition was found to be one of the mechanisms controlling H 2 O 2 level. The discrepancy between the protein level and activity of SOD2 might also confirm these observations. Hydrogen peroxide might affect also SOD2 expression via ROS-sensitive transcription factors. The SOD2 protein level in subsequent grades of CRC differentiation also varies in a periodic manner: G 1 -increase, G 2 -decrease, G 3 -increase. However, its activity generally remains at the same level. It seems that inhibition by hydrogen peroxide also occurs here, but whereas progression of CRC in the clinical advancement causes an inflammatory state (and oxidative stress) due to the growth inside the intestine wall, the differentiation is the change of the histology and morphology of the cell and does not affects the redox state of the cell by itself. Therefore the changes of SOD protein level during differentiation could only be a secondary phenomenon dependent on the action of transcription factors that simultaneously control SOD's expression and participate in the regulation of cell differentiation.
The transcription factors AP-1 and NF-κB participate in the control of cell differentiation, and also in the regulation of expression of SOD1 and SOD2 (Borrello & Demple, 1997; Wang et al., 2002; Floryk & Huberman, 2005; Mehic et al., 2005) . The expression profile of AP-1 and NF-κB varies similarly in all stages of CRC clinical advancement. Probably those changes are a response to the changing redox conditions during cancer development. Since they are ROS-sensitive, the changes of their protein level might be a manifestation of the tumor cell adaptation to the increasing levels of ROS. However, the protein levels of AP-1 and NF-κB, seems not to be directly related to the SOD1 and SOD2 protein levels. This suggests participation of other ROS-sensitive transcription factors, and regulation of SOD expression by a more complicated network of intracellular signaling (Seo et al., 1996; Hyoung-Pyo et al., 1999; Gopalakrishna & Jaken, 2000; Guo et al., 2003) .
In the subsequent stages of CRC differentiation the protein level of AP-1 varies in a periodic manner, and the protein level of NF-κB decreases. The two transcription factors regulate differentiation in opposite manner. Their expression profile leads eventually to full dedifferentiation in the G 3 grade. The high level of oxidative stress in grade G 1 might impair the activation and expression of AP-1 and NF-κB, in turn leading to initiation of changes in cell differentiation (Ryborg et al., 2004; Eliseev et al., 2006) .
The relations between the SOD protein levels and those of AP-1 and NF-κB in subsequent grades of CRC differentiation are unclear. Some protein levels of SOD and AP-1 and NF-κB change in similar manner, but this is not a rule, and influence of other factors cannot be ruled out.
The protein levels and activities of SOD isoenzymes (SOD1, SOD2) clearly change in subsequent stages of clinical advancement (UICC) and grades of differentiation (G) of human colorectal cancer. These changes seems to be dependent first of all on the clinical advancement of CRC (UICC). It is not clear if changes in SOD level are directly related to the differentiation process.
Our results also suggest that changes of protein level and activity of SOD isoenzymes might be an adaptive response to the oxidative stress, which appears during progression of CRC.
The participation of the AP-1 and NF-κB transcription factors in CRC progression seems to be mainly related to the stimulation of cell antioxidative response to oxidative stress. However, they also regulate such processes as proliferation, differentiation and apoptosis, and changes of their protein level, excessive activation, or impaired action might be a direct cause of carcinogenic transformation and further development of tumor disease.
It seems that the redox status of cancer cells has a great influence on tumor progression. SOD a) *significant versus control tissue (P < 0.05); **significant versus stage I of cancer (P < 0.05); ***significant versus stage II of cancer (P < 0.05); ****significant versus stage III of cancer (P < 0.05); I-IV, UICC stages of colorectal cancer clinical advancement; b) *significant versus control tissue (P < 0.05); **significant versus G 1 stage (P < 0.05); ***significant versus G 2 stage (P < 0.05); G 1 -G 3 , grades of colorectal cancer differentiation.
isoenzymes are one of the main controllers of the redox state, therefore therapies affecting SOD activity or expression (i.e., SOD inhibitors, gene knockout) in cancers at different stages of tumor advancement could aid in elimination of cancer cells.
